Edition:
United States

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

3.75USD
3:59pm EST
Change (% chg)

$-0.16 (-4.09%)
Prev Close
$3.91
Open
$3.97
Day's High
$3.99
Day's Low
$3.73
Volume
87,166
Avg. Vol
99,615
52-wk High
$10.23
52-wk Low
$3.73

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.29 -0.549
Jun '18 0.36 -0.595
Mar '18 0.15 -0.683
FY 2017 Dec '17
Sep '17 0.13 -0.706
Jun '17 0.00 -0.739
Mar '17 0.13 -0.805
FY 2016 Dec '16 0.08 -0.737
Sep '16 0.11 -0.657
Jun '16 0.10 -0.613
Mar '16 0.09 -0.561
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 1.19 5.43 0.00 0.06
Quarter Ending Mar-19 2 1.35 2.70 0.00 --
Year Ending Dec-18 5 1.94 6.24 0.60 0.46
Year Ending Dec-19 5 2.82 10.80 0.00 21.53
Earnings (per share)
Quarter Ending Dec-18 5 -0.56 -0.43 -0.73 -0.72
Quarter Ending Mar-19 3 -0.51 -0.41 -0.57 --
Year Ending Dec-18 4 -2.36 -2.26 -2.55 -2.94
Year Ending Dec-19 5 -2.27 -1.60 -3.11 -2.71
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta 1.00 0.66 0.95
Price to Sales (TTM) 244.68 242.95 21.76
Price to Book (MRQ) 1.96 18.87 4.53
Price to Tangible Book (MRQ) 1.96 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 131.75 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago 120.60 61.53 5.26
Sales - 5 Yr. Growth Rate -33.94 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 22.23 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago 17.31 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate 42.74 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.57 2.63
Current Ratio (MRQ) 8.01 6.87 3.68
LT Debt to Equity (MRQ) 38.62 16.70 9.53
Total Debt to Equity (MRQ) 38.66 21.89 13.39
Interest Coverage (TTM) -37.47 -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 54.80 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -11,143.71 -- --
EBITD - 5 Yr. Avg -4,786.89 -141.70 16.27
Operating Margin (TTM) -12,196.21 -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -5,953.60 -155.53 11.89
Pre-Tax Margin (TTM) -12,548.58 -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -6,588.50 -157.11 12.22
Net Profit Margin (TTM) -12,548.58 -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -6,588.50 -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 5,394 28,103,806 878,349,382
Net Income/Employee (TTM) -676,890 -3,710,889 102,474,711
Receivable Turnover (TTM) 1.47 9.19 5.49
Inventory Turnover (TTM) -- 2.64 3.99
Asset Turnover (TTM) 0.01 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -63.57 0.35 11.06
Return on Assets - 5 Yr. Avg. -52.57 2.90 11.85
Return on Investment (TTM) -71.80 0.60 13.80
Return on Investment - 5 Yr. Avg. -56.05 2.87 15.17
Return on Equity (TTM) -94.83 -2.18 15.29
Return on Equity - 5 Yr. Avg. -68.37 -0.88 16.29
  1 Year 3 Year 5 Year
Sales % -52.32 -52.99 -33.94
EPS (TTM) % -12.64 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellicum Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.96 2.98 99 99
13 Week -41.51 -36.82 37 94
26 Week -47.55 -47.40 42 96
52 Week -57.14 -58.43 41 98
YTD -50.42 -50.57 48 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 57.66%
# of Holders: 159
Total Shares Held: 25,001,058
3 Mo. Net Change: -1,343,538
# New Positions: 18
# Closed Positions: 10
# Increased Positions: 62
# Reduced Positions: 48
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.